Barbara Giesser, call 310-582-7613
Potential Microbiome Shift Weight-loss and appetite changes can alter gut flora
Since retatrutide is still in clinical trials and not yet FDA approved, we do not know the full picture, but based on what we know so far, the following people would not be good candidates: Individuals with a personal or family history of medullary thyroid cancer or MEN 2 (Multiple Endocrine Neoplasia syndrome type 2) Individuals with certain medical conditions, like pancreatitis
How health priorities and training strategies should evolve from early adulthood through older age [2:45]
Understanding why these symptoms occur, how to manage them effectively, and when to seek medical advice is essential for patients prescribed Rybelsus
By addressing obesity as a root cause, Zepbound offers a dual benefit of weight loss and improved sleep quality